Researchers find 12 compounds that inhibit tuberculosis bacterium's energy source

Researchers find 12 compounds that inhibit tuberculosis bacterium's energy source

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the door to new treatments for tuberculosis.

SUM Hospital launches free Cy-Tb test

Bhubaneswar, July 4: Mycobacterium tuberculosis antigen-based skin test, also known as Cy-Tb intra-dermal test, is now available in the Institute of Medical Sciences and SUM Hospital here.The test is conducted using an indigenous kit prepared by the Serum Institute of India, Prof. (Dr.) Banani Jena, Head of the Department of Respiratory Medicine in the hospital, said while addressing a Continuing Medical Education (CME) program on Friday. Prof. …

How does Mycobacterium tuberculosis manipulate host lysosomal pathways? - BioPatrika

Research Summary: Sulfolipid-1 from Mycobacterium tuberculosis activates TRPV4-mediated calcium influx in macrophages, promoting lysosomal biogenesis and remodeling, and revealing a previously unknown mechanism of host organelle manipulation by the pathogen. Author interview: Ibrahim Umar is a PhD student in Dr. Varadharajan Sundaramurthy’s lab at the National Centre for Biological Sciences (NCBS), India. He investigates the cell […] The post Ho…

University of Surrey researchers have made a breakthrough targeting dormant ‘zombie’ Tuberculosis cells.

TB is a bacterial infection which is spread through the air when a person with it coughs, sneezes or spits. Researchers have discovered the genes that help TB cells survive despite being exposed to antibiotics. They say disrupting these genes could lead to new drugs that shorten TB treatment and reduce antimicrobial resistance.